VolitionRx Limited (VNRX) Stock Analysis

Company Overview

The market values VolitionRx Limited (VNRX) at $6.61M. The company sits in the Healthcare sector, in the Medical Devices industry. Headcount on file is 57.

Over the past 52 weeks the price has ranged from $0.33 to $14.80. The most recent close on file for VNRX is $0.35, dated September 4, 2026. The close was unchanged from the previous session. The latest close sits 6.06% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $1.73M. Against the prior fiscal year total of $1.23M, that is a change of +40.04%. The same year closed with a net loss of $23.36M. The reported profit margin is 0%. That is 1.7 percentage points above the Medical Devices median of −1.69%. Trailing earnings per share are −3.85.

Across the 4 fiscal years on file, revenue moves from $306.39K in 2022 to $1.73M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. Measured against sales, the shares trade at 2.69 times revenue. On price-to-sales that is 9.67% below the Medical Devices median of 2.98. 151 Medical Devices companies report these metrics, and the medians quoted come from that group.

Beta against the wider market is reported at 1.1. Daily returns over the trailing 10 years annualize to a volatility of 83.22%. Over the trailing twelve months the price has returned −97.22%. Measured over 10 years, that is −41.69% a year compounded.

Growth & Income

The record shows no dividend for VNRX.

Across the complete calendar years on file, 2019 returned +161.88% and 2023 returned −70.37%. Of the 9 complete calendar years on file, 1 finished higher. So far in 2026 the price is −93.27%.